Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Jevtana

J&J drug offers hope in advanced prostate cancer

Men with advanced prostate cancer lived nearly four months longer on a new pill from Johnson & Johnson, according to keenly awaited study data that researchers said would change clinical practice.

Abiraterone, which could reach the market next year, provides a new option for men with an aggressive type of prostate cancer.

Its… J&J drug offers hope in advanced prostate cancer   



cyclind11 - fred hutchinson cancer research center1 - effective treatment of prostate cancer1 - bladder calculi1 - rsna1 - infections1 - significant incontinence6 - estradiol deficiency1 - nephrin1 - prophylactic intervention1 - halpin foundation1 - prognostic tests1 - renal cancer2 - autoimmune diseases1 - robot-assisted partial nephrectomy1 - anca-associated vasculitis1 - urethral diverticulum1 - hormone erythropoietin1 - aggressive bladder tumors1 - urinary obstruction1 - urs1 - chronic dialysis1 - nutrition1 - autism spectrum disorder1 - risk of prostate cancer2 - sexual changes1 - invasive treatment1 - mild hypertension1 - henoch-schönlein purpura1 - clinical nephrology conference1 -